Cite
APA Citation
Ward, B. J., Makarkov, A., Séguin, A., Pillet, S., Trépanier, S., Dhaliwall, J., Libman, M. D., Vesikari, T., & Landry, N. (2020). efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials. Lancet, 396(10261), 1491–1503. http://access.bl.uk/ark:/81055/vdc_100114886854.0x00004f